These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
331 related items for PubMed ID: 22932071
1. Procedural results and 30-day clinical events analysis following Edwards transcatheter aortic valve implantation in 48 consecutive patients: initial experience. Zhao QM, Lognone T, Ivascau C, Sabatier R, Roule V, Dahdouh Z, Massetti M, Grollier G. Chin Med J (Engl); 2012 Aug; 125(16):2807-10. PubMed ID: 22932071 [Abstract] [Full Text] [Related]
3. A meta-analysis of mortality and major adverse cardiovascular and cerebrovascular events in patients undergoing transfemoral versus transapical transcatheter aortic valve implantation using edwards valve for severe aortic stenosis. Panchal HB, Ladia V, Amin P, Patel P, Veeranki SP, Albalbissi K, Paul T. Am J Cardiol; 2014 Dec 15; 114(12):1882-90. PubMed ID: 25438917 [Abstract] [Full Text] [Related]
11. Clinical and hemodynamic outcomes of "all-comers" undergoing transapical aortic valve implantation: results from the Italian Registry of Trans-Apical Aortic Valve Implantation (I-TA). D'Onofrio A, Rubino P, Fusari M, Salvador L, Musumeci F, Rinaldi M, Vitali EO, Glauber M, Di Bartolomeo R, Alfieri OR, Polesel E, Aiello M, Casabona R, Livi U, Grossi C, Cassese M, Pappalardo A, Gherli T, Stefanelli G, Faggian GG, Gerosa G. J Thorac Cardiovasc Surg; 2011 Oct 15; 142(4):768-75. PubMed ID: 21840020 [Abstract] [Full Text] [Related]
13. Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis: results from an intermediate risk propensity-matched population of the Italian OBSERVANT study. D'Errigo P, Barbanti M, Ranucci M, Onorati F, Covello RD, Rosato S, Tamburino C, Santini F, Santoro G, Seccareccia F, OBSERVANT Research Group. Int J Cardiol; 2013 Sep 01; 167(5):1945-52. PubMed ID: 22633667 [Abstract] [Full Text] [Related]
15. Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry. Bosmans JM, Kefer J, De Bruyne B, Herijgers P, Dubois C, Legrand V, Verheye S, Rodrigus I, Belgian TAVI Registry Participants. Interact Cardiovasc Thorac Surg; 2011 May 01; 12(5):762-7. PubMed ID: 21349890 [Abstract] [Full Text] [Related]
16. Conduction disturbances and permanent cardiac pacing after transcatheter implantation of the CoreValve aortic bioprosthesis: initial single centre experience. Czerwińska K, Hryniewiecki T, Oręziak A, Dąbrowski M, Michałowska I, Witkowski A, Demkow M, Stępińska J, Orłowska Baranowska E, Rużyłło W. Kardiol Pol; 2012 May 01; 70(2):121-8. PubMed ID: 22427074 [Abstract] [Full Text] [Related]
17. The incidence of transcatheter aortic valve implantation-related heart block in self-expandable Medtronic CoreValve and balloon-expandable Edwards valves. Liang M, Devlin G, Pasupati S. J Invasive Cardiol; 2012 Apr 01; 24(4):173-6. PubMed ID: 22477754 [Abstract] [Full Text] [Related]
18. Heart failure in severe aortic valve stenosis: prognostic impact of left ventricular ejection fraction and mean gradient on outcome after transcatheter aortic valve implantation. Gotzmann M, Rahlmann P, Hehnen T, Müller P, Lindstaedt M, Mügge A, Ewers A. Eur J Heart Fail; 2012 Oct 01; 14(10):1155-62. PubMed ID: 22782969 [Abstract] [Full Text] [Related]